Unpredictability of glaucoma progression

References

• Weinreb RN, Friedman DS, Fechtner RD, et al. Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol 2004;138:458-67
   PubMed Web of Science ®Google Scholar
• Susanna R Jr, Vessani RM. New findings in the evaluation of the optic disc in glaucoma diagnosis. Curr Opin Ophthalmol 2007;18:122-8
   PubMed Web of Science ®Google Scholar
• Quigley HA, Enger C, Katz J, et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 1994;112:644-9
   PubMed Web of Science ®Google Scholar
• Martus P, Stroux A, Budde WM, et al. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma. Am J Ophthalmol 2005;139:999-1009
   PubMed Web of Science ®Google Scholar
• Johnson CA, Sample PA, Zangwill LM, et al. Structure and function evaluation (SAFE): II. Comparison of optic disk and visual field characteristics. Am J Ophthalmol 2003;135:148-54
   PubMed Web of Science ®Google Scholar
• Susanna R Jr, Drance SM, Douglas GR. Disc hemorrhages in patients with elevated intraocular pressure. Occurrence with and without field changes. Arch Ophthalmol 1979;97:284-5
   PubMed Web of Science ®Google Scholar
• Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982;100:135-46
   PubMed Web of Science ®Google Scholar
• Harwerth RS, Carter-Dawson L, Shen F, et al. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci 1999;40:2242-50
   PubMed Web of Science ®Google Scholar
• Harwerth R, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol 2006;124:853-9
   PubMed Web of Science ®Google Scholar
• Artes PH, Chauhan BC. Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res 2005;24:333-54
   PubMed Web of Science ®Google Scholar
• Strouthidis NG, Scott A, Peter NM, et al. Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement. Invest Ophthalmol Vis Sci 2006;47:2904-10
   PubMed Web of Science ®Google Scholar
• Kerrigan-Baumrind LA, Quigley HA, Pease ME, et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000;41:741-8
   PubMed Web of Science ®Google Scholar
• Lee BB. Receptive field structure in the primate retina. Vision Res 1996;36:631-44
   PubMed Web of Science ®Google Scholar
• Meister M. Multineuronal codes in retinal signaling. Proc Natl Acad Sci USA 1996;93:609-14
   PubMed Web of Science ®Google Scholar
• Brusini P, Johnson CA. Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol 2007;52:156-79
   PubMed Web of Science ®Google Scholar
• Spry PG, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol 2002;47:158-73
   PubMed Web of Science ®Google Scholar
• Caprioli J, Garway-Heath DF. A critical reevaluation of current glaucoma management. Ophthalmology 2007;114:S1-S41
   PubMed Web of Science ®Google Scholar
• Weber AJ, Chen H, Hubbard WC, et al. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci 2000;41:1370-9
   PubMed Web of Science ®Google Scholar
• Yücel YH, Zhang Q, Weinreb RN, et al. Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci 2001;42:3216-22
   PubMed Web of Science ®Google Scholar
• Gupta N, Ang LC, Noël de Tilly L, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006;90:674-8
   PubMed Web of Science ®Google Scholar
• Hodapp E, Parrish RK II, Anderson DR: Clinical Decisions in Glaucoma. St. Louis: The C.V. Mosby Co., 1993. pp. 52-61
   Google Scholar
• Ansari I, Chauban BC, McCormick TA, et al. Comparison of conventional and pattern discrimination perimetry in a prospective study of glaucoma patients. Invest Ophthalmol Vis Sci 2000;41:4150-7
   PubMed Web of Science ®Google Scholar
• Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004;137:S3-S12
   PubMed Web of Science ®Google Scholar
• Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005;140:598-606
   PubMed Web of Science ®Google Scholar
• Olthoff CM, Schouten JS, van de Borne BW, et al. Noncompliance with ocularhypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 2005;112:953-61
   PubMed Web of Science ®Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13
   PubMed Web of Science ®Google Scholar
• Miglior S, Zeyen T, Pfeiffer N, et al. Results of the European Glaucoma Prevention Study. Ophthalmology 2005;112:366-75
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-97
   PubMed Web of Science ®Google Scholar
• Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-53
   PubMed Web of Science ®Google Scholar
• AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 2002;134:499-512
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hyman L, et al. Predicators of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology 2007;114:1965-72
   PubMed Web of Science ®Google Scholar
• Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111:1627-35
   PubMed Web of Science ®Google Scholar
• Ocular Hypertension Treatment Study Group & European Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 2007;114:10-19
   Google Scholar
• Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 2003;121:48-56
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology 2007;114:205-9
   PubMed Web of Science ®Google Scholar
• Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20
   PubMed Web of Science ®Google Scholar
• Parrish RK 2nd. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?. Curr Opin Ophthalmol 2006;17:138-41
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79
   PubMed Web of Science ®Google Scholar
• Mitchell P, Hourihan F, Sandbach J, et al. The relationship between glaucoma and myopia. The Blue Mountains Eye Study. Ophthalmology 1999;106:2010-15
   PubMed Web of Science ®Google Scholar
• Perdicchi A, Iester M, Scuderi G, et al. Visual field damage and progression in glaucomatous myopic eyes. Eur J Ophthalmol 2007;17:534-7
   PubMed Web of Science ®Google Scholar
• Mojon DS, Hess CW, Goldblum D, et al. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology 1999;106:1009-12
   PubMed Web of Science ®Google Scholar
• Onen SH, Mouriaux F, Berramdane L, et al. High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma. Acta Ophthalmol Scand 2000;78:638-41
   PubMedGoogle Scholar
• Mojon DS, Hess CW, Goldblum D, et al. Primary open-angle glaucoma is associated with sleep apnea syndrome. Ophthalmologica 2000;214:1115-18
   Web of Science ®Google Scholar
• Mojon DS, Hess CW, Goldblum D, et al. Normal-tension glaucoma is associated with sleep apnea syndrome. Ophthalmologica 2002;216:180-4
   PubMed Web of Science ®Google Scholar
• Boland MV, Quigley HA. Risk factors and open-angle glaucoma: classification and application. J Glaucoma 2007;16:406-18
   PubMed Web of Science ®Google Scholar
• Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med 2004;21:609-14
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Kang JH, Manson JE, et al. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology 2006;113:1081-6
   PubMed Web of Science ®Google Scholar
• Chopra V, Varma R, Francis BA, et al. Type 2 diabetes mellitus and the risk of open-angle glaucoma. The Los Angeles Latino Eye Study. Ophthalmology 2008;115:227-32
   PubMed Web of Science ®Google Scholar
• Caprioli J, Coleman AL. Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology 2008;115:1123-9
   PubMed Web of Science ®Google Scholar
• Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004;122:17-21
   PubMed Web of Science ®Google Scholar
• Jonas JB, Stroux A, Velten I, et al. Central corneal thickness correlated with glaucoma damage and rate of progression. Invest Ophthalmol Vis Sci 2005;46:1269-74
   PubMed Web of Science ®Google Scholar
• Shah H, Kniestedt C, Bostrom A, et al. Role of central corneal thickness on baseline parameters and progression of visual fields in open angle glaucoma. Eur J Ophthalmol 2007;17:545-9
   PubMed Web of Science ®Google Scholar
• Dueker DK, Singh K, Lin SC, et al. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology 2007;114:1779-87
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Preferred Practice Pattern. Primary Open-Angle Glaucoma. San Francisco: American Academy of Ophthalmology, 2005. pp. 1-19
   Google Scholar
• European Glaucoma Society. Terminology and Guidelines for Glaucoma, 2nd edn. Savona: Editrice DOGMA® S.r.l., 2003. pp. 26-7
   Google Scholar